Literature DB >> 2447056

Comparison of two synthetic progesterones on ventilation in normal males: CMA vs. MPA.

T Morikawa1, Y Tanaka, R Maruyama, Y Nishibayashi, Y Honda.   

Abstract

We administered chlormadinone acetate (CMA), medroxyprogesterone acetate (MPA), and placebo to 16 normal male subjects using a randomized double-blind crossover study. After CMA administration, minute alveolar ventilation increased by +1.04 +/- 0.22 (SE) 1/min (P less than 0.05) accompanied by decrements of arterial PCO2 (-4.0 +/- 1.0 Torr) (P less than 0.01) and [HCO3-] (-2.1 +/- 0.05 mM/l) (P less than 0.01). On the other hand, in the MPA runs the corresponding changes of the above parameters were +0.71 +/- 0.21 l/min (P less than 0.05), -2.9 +/- 0.6 Torr (P less than 0.01), and -1.3 +/- 0.3 mM/l (P less than 0.01), respectively. The slopes of hypoxic ventilatory and occlusion pressure response lines remained unchanged in hypocapnia after CMA or MPA ingestion, but they increased when entidal PCO2 was adjusted to the predrug level. The hypercapnic ventilatory and occlusion pressure response lines merely shifted to the left without changing their slopes with these agents. No significant differences in all the above parameters were found between CMA and MPA runs. We concluded that in the normal males the effect of CMA on ventilation was similar to that of MPA, despite the fact that the luteinizing activity of CMA was reported to be approximately 10 times higher than the latter.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447056     DOI: 10.1152/jappl.1987.63.4.1610

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  2 in total

1.  Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women.

Authors:  P A Cistulli; D J Barnes; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

Review 2.  Control of Ventilation in Health and Disease.

Authors:  Susmita Chowdhuri; M Safwan Badr
Journal:  Chest       Date:  2016-12-19       Impact factor: 9.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.